Marinomed Biotech AG is a Manufacturer/Innovator company operating in the pharmaceutical industry.
Marinomed Biotech AG is an Austrian biopharmaceutical company specializing in the development of innovative products based on IP protected technology platforms, such as Marinosolv(R) and Carragelose(R). The Solv4U partnerships program addresses the challenge of hardly soluble APIs in drug development and relies on the clinically proven technology Marinosolv(R) by customized aqueous formulations, in order to improve the bioavailability and thereby therapeutic efficacy.
Company type
Manufacturer/Innovator
Products and services
Pharmaceutical Packaging, APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Marinomed Biotech AG on LinkedIn
Address
Marinomed Biotech AG, Hovengasse 25, Korneuburg, Austria, 2100
